```html Drug Coverage Search

Select Your Role

Patient

Access a simplified interface to quickly find medication coverage and costs.

Healthcare Provider

Utilize advanced filters for in-depth medication coverage and alternatives search.

Loading...
```
Drug List Updates: Oct to Nov 2025 | Corporate Coverage Log

Drug Coverage Updates Log

DAMAN THIQA
November 2025 Coverage Update (Latest Version)

Drug List Updates: Oct to Nov 2025

Highlights of UPP Scope & Thiqa Plan changes.

Analyzing and merging data...

This log is provided for reference and compliance purposes. Please check back monthly for the latest updates.

سجل تحديثات تغطية التأمين | ضمان وثقة

سجل تحديثات تغطية التأمين الدوائية

ضمان (DAMAN) ثقة (THIQA)

نطاق وهدف الصفحة

هذا السجل هو مرجع أساسي لجميع الصيادلة والمختصين الطبيين العاملين مع خطط ضمان (DAMAN) و ثقة (THIQA).

تحديث الشهر - أكتوبر 2025 (October 2025 Update)

MANDATORY ACTION: Submission of eligibility request via **Open Jet** for each and every member visit. Failure to obtain the eligibility may affect the claims payment.

It is also mandatory to use the **correct doctor code** when checking eligibility; using a random code is **not permitted.**

Omega-3 Acid Ethyl Esters & Icosapent Ethyl (VASCEPA)

Coverage Criteria and Restrictions:

  • Patients with triglyceride levels **≥ 500 mg/dL**, OR **≥ 400 mg/dL** and not controlled by **STATINS**.
  • Not considered first-line therapy for hypertriglyceridemia (only if **statins** and/or **fibrates** failed to control or were not tolerated).
  • Only covered for hypertriglyceridemia, not for any other condition.
  • Prescribing is restricted to: **Cardiology, Internal Medicine, Endocrinology, and Family Medicine.**
  • Non covered for patients under 18 years.
Ondansetron – Approved Indications Only

Approved Indications Only:

  • Chemotherapy-Induced Nausea and Vomiting (**CINV**)
  • Postoperative Nausea and Vomiting (**PONV**)
  • Radiotherapy-Induced Nausea and Vomiting (**RINV**)
  • Cyclic Vomiting Syndrome in Children
  • **Hyperemesis Gravidarum:**
    • Pregnancy between 4 and 20 weeks with moderate to severe symptoms.
    • Use of ondansetron before 10 weeks of gestation is associated with a small increased risk of oral clefts. It should only be considered when first-line treatments have failed or if complications like dehydration or poor oral intake threaten maternal or fetal health.
    • **Pregnant Patients Beyond 20 Weeks of Gestation:** Coverage will be considered on a case-by-case basis, as most patients experience resolution of nausea and vomiting after 20 weeks. Therapy beyond this period is typically reserved for rare cases requiring medical justification.
  • Patients presenting to the emergency department with severe, self-limiting nausea and vomiting due to causes such as viral gastroenteritis, acute mountain sickness, palliative care, or other medical conditions should be treated in emergency settings.
**Warning:** Ondansetron is **not covered** for general or unexplained nausea/vomiting outside of the approved clinical indications above.
VIT D 10,000 IU Drops – Coverage Restrictions

Coverage Conditions (Adult Patients Only):

  • Dysphagia or diagnosis related to difficulty in swallowing.
  • Intestinal malabsorption.
  • Elderly patients **above 70 years of age.**

Note: This applies to adult patients only and requires one of the above conditions to be met.

THIQA Category 1 (C1) Coverage and Auto Renewal Policy

Auto Renewal Policy (Medication Duration):

  • The auto renewal of **THIQA C1** members is applicable **only to UAE nationals.** Medications to be dispensed as per **prescription duration.**

Non-UAE Nationals Verification:

  • For **non-UAE national THIQA C1 members**, please **verify eligibility** before providing any services.
  • Medications to be dispensed only till the **expiry date of the card.**

Final Reminder: Any claims rejected due to **missing eligibility verification** or **wrong doctor code** will be under the **responsibility of the pharmacist.**

سجل تحديثات التأمين مقدم للأغراض المرجعية والامتثال.

يُرجى العودة إلى هذه الصفحة شهريًا للحصول على أحدث التحديثات.

Created with